Navamedic ASA: Mandatory notification of trade
Kathrine Gamborg Andreassen, Chief Executive Officer of Navamedic ASA, has today, on 30 September 2020, exercised 125,000 share options in Navamedic ASA with a strike price of NOK 8.88 per share, and in connection with the exercise subscribed for 125,000 new shares in Navamedic ASA.
Following the issue of the new shares, Kathrine Gamborg Andreassen will transfer the shares to her wholly-owned investment company, Soleglad Invest AS.
Following the issue of the new shares in Navamedic ASA, Kathrine Gamborg Andreassen, with her related parties, will own 666,668 shares and 105,000 options in Navamedic ASA.
This information is subject of the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.